Patients with positive skin test results to penicillin should not undergo penicillin or amoxicillin challenge - 05/03/15
Doi : 10.1016/j.jaci.2014.08.045
Miguel A. Park, MD a 
, Roland Solensky, MD a, David A. Khan, MD b, Mariana C. Castells, MD, PhD c, Eric M. Macy, MD e, David M. Lang, MD d
, Roland Solensky, MD a, David A. Khan, MD b, Mariana C. Castells, MD, PhD c, Eric M. Macy, MD e, David M. Lang, MD d a Adverse Reactions to Drugs, Biologicals, and Latex Committee, American Academy of Allergy, Asthma & Immunology, Milwaukee, Wis
b Food Allergy, Anaphylaxis, Dermatology and Drug Allergy Interest Section, American Academy of Allergy, Asthma & Immunology, Milwaukee, Wis
c Board of Directors, American Academy of Allergy, Asthma & Immunology, Milwaukee, Wis
d Practice and Policy Division, American Academy of Allergy, Asthma & Immunology, Milwaukee, Wis
e Department of Allergy, Southern California Permanente Medical Group, San Diego Medical Center, San Diego, Calif
| Disclosure of potential conflict of interest: R. Solensky has received consultancy fees from Optimer Pharmaceuticals, is employed by the Corvallis Clinic, and has received or has grants pending from Allerquest and Merck. D. A. Khan has received payment for delivering lectures from Genentech, Baxter, and Merck. M. C. Castells has received consultancy fees from Merck and Sanofi, is employed by Brigham and Women's Hospital, has received or has grants pending from the National Institutes of Health, receives royalties from UpToDate, and has received compensation for travel and other meeting-related expenses from the American Academy of Allergy, Asthma & Immunology (AAAAI). E. M. Macy is employed by the Southern California Permanente Medical Group, which has received funding from ALK, as well as consultancy fees from BioMarin and Ultragenyx. D. M. Lang serves on the AAAAI Board of Directors; has received consultancy fees from Merck, Quest, and Hycor; and has received or has grants pending from Merck, Genentech, and Novartis, from which he has also received payment for delivering lectures. M. A. Park declares no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 135 - N° 3
P. 816-817 - mars 2015 Retour au numéro
Article précédent
- Postmenopausal hormone therapy and asthma-related hospital admission
- Klaus Bønnelykke, Ole Raaschou-Nielsen, Anne Tjønneland, Charlotte Suppli Ulrik, Hans Bisgaard, Zorana Jovanovic Andersen
- Long-term consequences of Hodgkin lymphoma therapy on T-cell lymphopoiesis
- Isabelle Pellier, Gilles Renier, Josué Rakotonjanahary, Marie Audrain, Elsa Berardi, Martine Gardembas, Aline Clavert, Marie Pierre Moles, Stéphanie Proust-Houdemont, Yves Reguerre, Emilie De Carli, Martine Georgin-Mege, Erwan Garo, Simon Blanchard, Charline Miot, Capucine Picard, Yves Delneste, Alain Fischer, Aline Tanguy-Schmidt, Pascale Jeannin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?